Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02466867Phase 4Completed
A Phase 4 trial of naftifine organogel (MediQuest Therapeutics) in tinea corporis, sponsored by Merz. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02466867.